Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.48 |
| ▸ | YARS1 | P54577 | 2/20 | 0.47 |
| ▸ | MME | P08473 | 2/20 | 0.47 |
| ▸ | ACE | P12821 | 2/20 | 0.45 |
| ▸ | CPA1 | P15085 | 1/20 | 0.44 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.43 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4434143 | 1.00 | SLC7A5 (0.48) | SLC7A5YARS1MMEACECPA1 | |
| SCHEMBL23598458 | 1.00 | SLC7A5 (0.48) | SLC7A5YARS1MMEACECPA1 | |
| SCHEMBL9665005 | 1.00 | SLC7A5 (0.48) | SLC7A5YARS1MMEACECPA1 | |
| SCHEMBL9664998 | 1.00 | SLC7A5 (0.48) | SLC7A5YARS1MMEACECPA1 | |
| Hydrochloric Acid SCHEMBL20335514 | 0.99 | SLC7A5 (0.47) | SLC7A5YARS1MMEACECPA1 | |
| Hydrochloric Acid SCHEMBL924823 | 0.99 | SLC7A5 (0.47) | SLC7A5YARS1MMEACECPA1 | |
| SCHEMBL31553196 | 0.98 | YARS1 (0.46) | SLC7A5YARS1MMEOPRM1OPRD1 | |
| SCHEMBL31259944 | 0.97 | MME (0.47) | SLC7A5YARS1MMEACEOPRM1 | |
| SCHEMBL31006409 | 0.97 | MME (0.47) | SLC7A5YARS1MMEACEOPRM1 | |
| SCHEMBL38650869 | 0.97 | MME (0.47) | SLC7A5YARS1MMEACEOPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026044253-A1 | GENETICALLY ENCODED FLUORESCENT SENSORS FOR VISUALIZING POLYAMINE LEVELS, UPTAKE, AND DISTRIBUTION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-02-26 | — | — | WO | claimed |
| EP-4659591-A1 | TASTE-ENHANCING COMPOSITION, METHOD FOR PRODUCING SAME, FOOD PRODUCT, AND METHOD FOR ENHANCING TASTE OF FOOD PRODUCT | House Foods Group Inc. (JP) | 2025-12-10 | — | — | EP | claimed |
| EP-4659592-A1 | FLAVOR ENHANCING COMPOSITION, MANUFACTURING METHOD THEREFOR, AND METHOD FOR ENHANCING FLAVOR OF FOOD PRODUCT | House Foods Corporation (JP) | 2025-12-10 | — | — | EP | claimed |
| WO-2024162421-A1 | FLAVOR ENHANCING COMPOSITION, MANUFACTURING METHOD THEREFOR, AND METHOD FOR ENHANCING FLAVOR OF FOOD PRODUCT | ハウス食品株式会社 | 2024-08-08 | — | — | WO | claimed |
| WO-2024162422-A1 | TASTE-ENHANCING COMPOSITION, METHOD FOR PRODUCING SAME, FOOD PRODUCT, AND METHOD FOR ENHANCING TASTE OF FOOD PRODUCT | ハウス食品グループ本社株式会社 | 2024-08-08 | — | — | WO | claimed |
| CN-116769860-A | Enzymatic hydrolysis of crayfish shells, oligopeptide family extracted from crayfish shells and application of crayfish shells | 奇明达(北京)植物药物技术开发有限公司 | 2023-09-19 | — | — | CN | claimed |
| WO-2026089752-A1 | COMPOSITIONS AND METHODS FOR MICROSPHERE DELIVERY OF THERAPEUTIC PEPTIDES | Finitus, LLC (US) | 2026-04-30 | — | — | WO | disclosed |
| WO-2026089754-A1 | COMPOSITIONS AND METHODS FOR INTRANASAL DELIVERY OF THERAPEUTIC PEPTIDES | Finitus, LLC (US) | 2026-04-30 | — | — | WO | disclosed |
| US-20260108467-A1 | COMPOSITIONS AND METHODS FOR MICROSPHERE DELIVERY OF THERAPEUTIC PEPTIDES | FINITUS LLC (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260108583-A1 | COMPOSITIONS AND METHODS FOR INTRANASAL DELIVERY OF THERAPEUTIC PEPTIDES | FINITUS LLC (US) | 2026-04-23 | — | — | US | disclosed |
| WO-2026044253-A1 | GENETICALLY ENCODED FLUORESCENT SENSORS FOR VISUALIZING POLYAMINE LEVELS, UPTAKE, AND DISTRIBUTION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-02-26 | — | — | WO | disclosed |
| EP-4665839-A1 | CELL CULTURE MEDIA | Merck Patent GmbH (DE) | 2025-12-24 | — | — | EP | disclosed |
| EP-4659591-A1 | TASTE-ENHANCING COMPOSITION, METHOD FOR PRODUCING SAME, FOOD PRODUCT, AND METHOD FOR ENHANCING TASTE OF FOOD PRODUCT | House Foods Group Inc. (JP) | 2025-12-10 | — | — | EP | disclosed |
| US-20220112237-A1 | AMINO ACID COMPOSITION HAVING CO-AMORPHOUS STRUCTURE | AJINOMOTO CO., INC. (JP) | 2022-04-14 | — | — | US | disclosed |
| US-20140343865-A1 | Biomarkers for Kidney Cancer and Methods Using the Same | METABOLON, INC. | 2014-11-20 | — | — | US | disclosed |
| EP-2788763-A2 | BIOMARKERS FOR KIDNEY CANCER AND METHODS USING THE SAME | Metabolon, Inc. (US) | 2014-10-15 | — | — | EP | disclosed |
| WO-2013086365-A2 | BIOMARKERS FOR KIDNEY CANCER AND METHODS USING THE SAME | METABOLON, INC. (US) | 2013-06-13 | — | — | WO | disclosed |
| EP-2120846-A2 | USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS | BASF SE (DE) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008107347-A2 | USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS | BASF SE (CH) | 2008-09-12 | — | — | WO | disclosed |
| JP-2003252897-A | L-TYROSYL-L-HISTIDINE OF UNDARIA PINNATIFIDA PEPTIDE AND DEPRESSOR | SUETSUNA YOKO | 2003-09-10 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260108583-A1 | COMPOSITIONS AND METHODS FOR INTRANASAL DELIVERY OF THERAPEUTIC PEPTIDES | MUC1, VIP, LGALS4 | SLC7A5 1763/4885YARS1 3519/4885MME 522/4885 |
| US-20260108467-A1 | COMPOSITIONS AND METHODS FOR MICROSPHERE DELIVERY OF THERAPEUTIC PEPTIDES | FGF23, FIBP, PTMS | SLC7A5 60/4885YARS1 1050/4885MME 1131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.